The Discounted Cash Flow (DCF) valuation of Thyrocare Technologies Ltd (THYROCARE.NS) is 403.24 INR. With the latest stock price at 1,081.85 INR, the upside of Thyrocare Technologies Ltd based on DCF is -62.7%.
Based on the latest price of 1,081.85 INR and our DCF valuation, Thyrocare Technologies Ltd (THYROCARE.NS) is a sell. selling THYROCARE.NS stocks now will result in a potential gain of 62.7%.
| Range | Selected | |
| WACC / Discount Rate | 10.7% - 13.4% | 12.0% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 319.25 - 556.52 | 403.24 |
| Upside | -70.5% - -48.6% | -62.7% |